Boothbay Fund Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-390
Closed -$1.84M 1827
2020
Q4
$1.84M Sell
390
-184
-32% -$8.54K 0.07% 289
2020
Q3
$2.67M Sell
574
-308
-35% -$10.6K 0.16% 152
2020
Q2
$3.18M Buy
+882
New +$32.5K 0.22% 107

Other funds holding ZYME

Boothbay Fund Management's ZYME Position: Q4 2025 in Review

Boothbay Fund Management sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 32,757 shares — an estimated $559K sold.

Boothbay Fund Management first reported a position in ZYME in Q2 2019 and held it in 3 quarters. The position peaked at $559K in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Boothbay Fund Management reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 32,757 Zymeworks shares in Q4 2025, an estimated $559K.
  • Boothbay Fund Management first reported a position in Zymeworks in Q2 2019 and held it in 3 quarters.
  • Boothbay Fund Management's Zymeworks position peaked at $559K in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.